SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRYO-CELL (CCEL) -- Ignore unavailable to you. Want to Upgrade?


To: CUBBY who wrote (18)9/14/1999 7:39:00 AM
From: CUBBY  Read Replies (1) | Respond to of 53
 
CRYO-CELL Announces 3rd Quarter Results


September 13, 1999 05:58 PM
CLEARWATER, Fla., Sept. 13 /PRNewswire/ -- Jill Taymans, Chief Financial Officer of CRYO-CELL International, Inc. CCEL , announced the company's third quarter sales results for the period ending August 31, 1999.
Gerald F. Maass, Executive Vice President and General Manager, commented, "It is extremely encouraging to continue to see growth in both our quarter-to-quarter sales, as well as, our year-to-date results. August was an especially good month with both record sales and increases of 36% in information requests and enrollments over July. Referrals from satisfied clients are now the second largest source of enrollment information requests."

Highlights of the quarterly sales results include the following:

* Q3, 1999 sales of $330,824 represent a 199% increase over Q3, 1998 sales of $110,650

* YTD sales (9 months) of $862,040 represent a 333% increase over 1998 sales of $199,125 for the same period

* Q3 sales represent a 6% increase over Q2 sales of $311,749

Solid gains have once again resulted from the extensive marketing program with Lamaze Publishing and the Internet. CRYO-CELL is the exclusive cord blood sponsor, with renewal rights, of the Lamaze You and Your Baby educational video. Lamaze Publishing Inc. was recently acquired by iVillage, Inc., who will honor the agreements in place with Lamaze Publishing.

The company will complete its 10-Q filing by October 15, 1999. Included in that filing will be the impact of the pending settlement with the University of Arizona. The University's Board of Regents has approved an $800,000 settlement for their breach of contract with CRYO-CELL and misappropriation of CRYO-CELL's trade secrets.

CRYO-CELL offers America's most affordable U-Cord(TM) storage program. Expectant parents call 800-STOR-CELL, (800-786-7235), or visit our Web site, www.cryo-cell.com .

CRYO-CELL is a publicly traded company. Its common stock trades on The Nasdaq Stock Market(R) under the symbol ... CCEL .

Forward-Looking Statement

Statements wherein the terms "believes", "intends", or "expects" as used are intended to reflect "forward-looking statements" of the Company. The information contained herein is subject to various risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated in such forward looking statements or paragraphs. Readers should carefully review the risk factors described in other documents the Company files from time to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K filed by the Company.

SOURCE CRYO-CELL International, Inc.

cubby